UK markets closed

National HealthCare Corporation (NHC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
91.47-1.94 (-2.08%)
At close: 04:00PM EDT
91.47 -0.16 (-0.17%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.41B
Enterprise value 1.28B
Trailing P/E 21.08
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.23
Price/book (mrq)1.55
Enterprise value/revenue 1.12
Enterprise value/EBITDA 9.75

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 364.40%
S&P500 52-week change 322.38%
52-week high 3101.81
52-week low 356.36
50-day moving average 392.77
200-day moving average 380.84

Share statistics

Avg vol (3-month) 366.49k
Avg vol (10-day) 343.9k
Shares outstanding 515.4M
Implied shares outstanding 615.72M
Float 812.32M
% held by insiders 119.62%
% held by institutions 157.82%
Shares short (15 Apr 2024) 4513.97k
Short ratio (15 Apr 2024) 47.9
Short % of float (15 Apr 2024) 44.55%
Short % of shares outstanding (15 Apr 2024) 43.34%
Shares short (prior month 15 Mar 2024) 4456.82k

Dividends & splits

Forward annual dividend rate 42.36
Forward annual dividend yield 42.58%
Trailing annual dividend rate 32.34
Trailing annual dividend yield 32.51%
5-year average dividend yield 43.09
Payout ratio 453.92%
Dividend date 301 May 2024
Ex-dividend date 427 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 5.88%
Operating margin (ttm)4.73%

Management effectiveness

Return on assets (ttm)2.48%
Return on equity (ttm)7.30%

Income statement

Revenue (ttm)1.14B
Revenue per share (ttm)74.15
Quarterly revenue growth (yoy)11.60%
Gross profit (ttm)N/A
EBITDA 93.26M
Net income avi to common (ttm)66.8M
Diluted EPS (ttm)4.34
Quarterly earnings growth (yoy)347.10%

Balance sheet

Total cash (mrq)223.62M
Total cash per share (mrq)14.57
Total debt (mrq)93.39M
Total debt/equity (mrq)10.26%
Current ratio (mrq)1.89
Book value per share (mrq)59.20

Cash flow statement

Operating cash flow (ttm)111.22M
Levered free cash flow (ttm)57.9M